Followers | 697 |
Posts | 34939 |
Boards Moderated | 3 |
Alias Born | 05/30/2011 |
Tuesday, October 24, 2023 10:36:07 AM
Recent MAIA News
- MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement • Business Wire • 04/30/2024 12:08:00 PM
- MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement • Business Wire • 04/29/2024 12:08:00 PM
- MAIA Biotechnology Announces $1.00 Million Private Placement • Business Wire • 04/23/2024 12:51:00 PM
- MAIA Biotechnology to Present at Two Investor Conferences in April 2024 • Business Wire • 04/05/2024 12:01:00 PM
- MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero • Business Wire • 03/28/2024 07:00:00 PM
- MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement • Business Wire • 03/26/2024 07:00:00 PM
- MAIA Biotechnology Announces $1.33 Million Private Placement • Business Wire • 03/26/2024 12:01:00 PM
- MAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placement • Business Wire • 03/22/2024 07:00:00 PM
- MAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory Board • Business Wire • 03/21/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:15:28 PM
- MAIA Biotechnology to Participate in the 36th Annual ROTH Conference • Business Wire • 03/07/2024 02:45:00 PM
- MAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meeting • Business Wire • 03/06/2024 04:04:00 PM
- MAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer Patients • Business Wire • 03/06/2024 01:48:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 01:00:38 PM
- MAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to Shareholders • Business Wire • 03/05/2024 01:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 10:23:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:17:06 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/14/2024 10:18:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 10:15:18 PM
- MAIA Biotechnology Announces Publication in Nature Communications on Positive Effects of THIO for Potential Treatment of Small Cell Lung Cancer • Business Wire • 02/07/2024 01:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 02:00:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:10:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:08:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:07:25 PM
- MAIA Biotechnology Announces Publication of International PCT Patent Application Covering Anticancer Telomere-Targeting Compounds • Business Wire • 01/24/2024 12:15:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM